FDA Inspection 1198059 — LifeStream Blood Bank
The FDA completed an inspection of LifeStream Blood Bank on Feb 8, 2023 in Riverside, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 8, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Riverside, CA (United States)